Manulife (Manufacturers Life Insurance)’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-54,981	Closed	-$348K	–	3011
2022 Q2	$348K	Hold	54,981	–	–	﹤0.01%	2290
2022 Q1	$194K	Buy	+54,981	New	+$203K	﹤0.01%	2786
2018 Q3	–	Sell	-151	Closed	-$7K	–	4014
2018 Q2	$7K	Hold	151	–	–	﹤0.01%	4017
2018 Q1	$9K	Buy	151 +22	+17%	+$1.16K	﹤0.01%	3966
2017 Q4	$7K	Sell	129 -16	-11%	-$952	﹤0.01%	4078
2017 Q3	$10K	Buy	+145	New	+$8.3K	﹤0.01%	3845

Other funds holding FSTX

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DMKJ

David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s FSTX Position: Q3 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2022, closing a stake of 54,981 shares — an estimated $348K sold.

Manulife (Manufacturers Life Insurance) first reported a position in FSTX in Q3 2017 and held it in 6 quarters. The position peaked at $348K in Q2 2022. 54 funds tracked by Wall St. Rank hold FSTX as of Q3 2022.

Manulife (Manufacturers Life Insurance) reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 54,981 F-star Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $348K.
Manulife (Manufacturers Life Insurance) first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
Manulife (Manufacturers Life Insurance)'s F-star Therapeutics, Inc. Common Stock position peaked at $348K in Q2 2022.
54 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2022, filed 3 Nov 2022.